Tools commonly used in the Medications Wholesale (Manufacturing) industry for day-to-day tasks and operations.

• High-performance liquid chromatography (HPLC)
• Gas chromatography (GC)
• Mass spectrometry (MS)
• Ultraviolet-visible spectroscopy (UV-Vis)
• Infrared spectroscopy (IR)
• Nuclear magnetic resonance (NMR)
• Particle size analyzer
• Dissolution tester
• Stability chambers
• Moisture analyzer

Common products and services typical of NAICS Code 325412-15, illustrating the main business activities and contributions to the market.

• Antibiotics
• Antidepressants
• Antihistamines
• Antipsychotics
• Blood pressure medications
• Chemotherapy drugs
• Diabetes medications
• Pain relievers
• Respiratory medications
• Vaccines

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Good Manufacturing Practice (GMP): GMP is a set of regulations enforced by the FDA to ensure that pharmaceutical products are consistently produced and controlled according to quality standards. The FDA provides GMP certification to pharmaceutical manufacturers in the US.
• Drug Enforcement Administration (DEA) Registration: The DEA registration is required for manufacturers, distributors, and dispensers of controlled substances. The DEA ensures that these entities comply with the Controlled Substances Act.
• National Drug Code (NDC) Registration: The NDC is a unique identifier assigned to each medication. Manufacturers must register with the FDA to obtain an NDC number for their products.
• Occupational Safety and Health Administration (OSHA) Certification: OSHA provides certification for pharmaceutical manufacturers to ensure that they comply with safety regulations in the workplace.
• Environmental Protection Agency (EPA) Certification: The EPA provides certification for pharmaceutical manufacturers to ensure that they comply with environmental regulations.

A concise historical narrative of NAICS Code 325412-15 covering global milestones and recent developments within the United States.

• The Medications Wholesale (Manufacturing) industry has a long history dating back to the early 20th century when the first pharmaceutical companies began to emerge. The industry has since undergone significant changes, with the introduction of new technologies and the development of new drugs. In the United States, the industry has seen a significant increase in demand for medications due to the aging population and the rise of chronic diseases. Notable advancements in the industry include the development of insulin in the 1920s, the introduction of antibiotics in the 1940s, and the discovery of new treatments for cancer and HIV in the 1980s and 1990s. Recent history of the Medications Wholesale (Manufacturing) industry in the United States has been marked by a number of significant events. In 2010, the Affordable Care Act was signed into law, which expanded access to healthcare and increased demand for medications. The industry has also seen a rise in the use of generic drugs, which has led to increased competition and lower prices. In addition, the industry has been impacted by the opioid epidemic, which has led to increased scrutiny of prescription drug use and sales. Overall, the industry has continued to grow and evolve, with new drugs and treatments being developed to meet the changing needs of patients.

The anticipated future trajectory of the NAICS 325412-15 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Stable

  The future outlook for the Medications Wholesale (Manufacturing) industry in the USA is positive. The industry is expected to grow due to the increasing demand for pharmaceuticals and the aging population. The COVID-19 pandemic has also increased the demand for medications, which has positively impacted the industry. The industry is also expected to benefit from the increasing use of technology in the manufacturing process, which will lead to increased efficiency and cost savings. However, the industry may face challenges such as increasing competition and regulatory changes. Overall, the industry is expected to continue to grow in the coming years.

Recent groundbreaking advancements and milestones in the Medications Wholesale (Manufacturing) industry, reflecting notable innovations that have reshaped its landscape.

• Use Of Artificial Intelligence (AI) In the Manufacturing Process: AI is being used to improve the efficiency and accuracy of the manufacturing process. It is being used to analyze data and identify patterns that can help improve the manufacturing process.
• 3D Printing: 3D printing is being used to manufacture medications. This technology allows for the production of complex shapes and structures that are difficult to produce using traditional manufacturing methods.
• Personalized Medicine: The industry is moving towards personalized medicine, which involves tailoring medications to individual patients. This approach is expected to improve patient outcomes and reduce healthcare costs.
• Blockchain Technology: Blockchain technology is being used to improve the supply chain management of medications. It allows for greater transparency and traceability, which can help reduce the risk of counterfeit medications.
• Gene Editing: Gene editing is being used to develop new medications. This technology allows for the modification of genes, which can lead to the development of new treatments for diseases.